Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
24,362,024
-
Shares change
-
-164,149
-
Total reported value, excl. options
-
$405,654,613
-
Value change
-
-$5,856,715
-
Number of buys
-
24
-
Number of sells
-
-33
-
Price
-
$19.90
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q1 2018
71 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q1 2018.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,362,024 shares
of 66,399,673 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4,912,306 shares), TRV GP, LLC (3,981,437 shares), ORBIMED ADVISORS LLC (2,901,295 shares), MPM ASSET MANAGEMENT LLC (2,696,392 shares), BAKER BROS. ADVISORS LP (2,049,020 shares), FMR LLC (1,295,800 shares), JANUS HENDERSON GROUP PLC (1,094,620 shares), PERCEPTIVE ADVISORS LLC (592,286 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (582,010 shares), and WELLINGTON MANAGEMENT GROUP LLP (545,256 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.